U.S. flag

An official website of the United States government

NM_000251.3(MSH2):c.192C>G (p.Ile64Met) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jun 21, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002271568.1

Allele description [Variation Report for NM_000251.3(MSH2):c.192C>G (p.Ile64Met)]

NM_000251.3(MSH2):c.192C>G (p.Ile64Met)

Gene:
MSH2:mutS homolog 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p21
Genomic location:
Preferred name:
NM_000251.3(MSH2):c.192C>G (p.Ile64Met)
HGVS:
  • NC_000002.12:g.47403383C>G
  • NG_007110.2:g.5260C>G
  • NM_000251.3:c.192C>GMANE SELECT
  • NM_001258281.1:c.-7C>G
  • NP_000242.1:p.Ile64Met
  • NP_000242.1:p.Ile64Met
  • LRG_218t1:c.192C>G
  • LRG_218:g.5260C>G
  • LRG_218p1:p.Ile64Met
  • NC_000002.11:g.47630522C>G
  • NM_000251.2:c.192C>G
Protein change:
I64M
Links:
dbSNP: rs1395172053
NCBI 1000 Genomes Browser:
rs1395172053
Molecular consequence:
  • NM_001258281.1:c.-7C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000251.3:c.192C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002556046Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Jun 21, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach.

Rosa RCA, Santis JO, Teixeira LA, Molfetta GA, Dos Santos JTT, Ribeiro VDS, Chahud F, Ribeiro-Silva A, Brunaldi MO, Silva WA Jr, Ferraz VEF.

Gynecol Oncol. 2020 Oct;159(1):229-238. doi: 10.1016/j.ygyno.2020.07.013. Epub 2020 Jul 18.

PubMed [citation]
PMID:
32694065

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002556046.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: MSH2 c.192C>G (p.Ile64Met) results in a conservative amino acid change located in the DNA mismatch repair protein MutS-like, N-terminal doomain (IPR007695) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 230350 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.192C>G has been reported in the literature in an individual affected with endometrial carcinomas who carried a pathogenic PMS2 vairant (Rosa_2020). This report does not provide unequivocal conclusions about association of the variant with Lynch Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024